XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues [Abstract]    
Net revenue $ 131,704 $ 112,368
Operating cost:    
Salaries and related costs 75,149 63,815
Rent, supplies, contract labor and other 28,662 21,457
Provision for credit losses 1,305 1,200
Total operating cost 105,116 86,472
Gross profit 26,588 25,896
Corporate office costs 11,556 10,874
Operating income 15,032 15,022
Other income and expense    
Equity in earnings of unconsolidated affiliate 339 0
Interest and other income, net 46 54
Gain on revaluation of put-right liability 603 0
Interest expense - debt and other (540) (246)
Total other income and expense 448 (192)
Income before taxes 15,480 14,830
Provision for income taxes 3,498 2,944
Net income 11,982 11,886
Less: net income attributable to non-controlling interest:    
Redeemable non-controlling interest - temporary equity (2,557) (2,453)
Non-controlling interest - permanent equity (626) (1,260)
Net income attributable to non-controlling interest (3,183) (3,713)
Net income attributable to USPH shareholders $ 8,799 $ 8,173
Basic earnings per share attributable to USPH shareholders (in dollars per share) $ 0.67 $ 0.21
Diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 0.67 $ 0.21
Shares used in computation - basic (in shares) 12,937 12,870
Shares used in computation - diluted (in shares) 12,937 12,870
Dividends declared per common share (in dollars per share) $ 0.41 $ 0.35
Net Patient Revenue [Member]    
Revenues [Abstract]    
Net revenue $ 109,538 $ 99,254
Other Revenue [Member]    
Revenues [Abstract]    
Net revenue $ 22,166 $ 13,114